Platelet rebound effect

New class of platelet blockers proves effective in phase III trial

medicalxpress.com — “Adding vorapaxar, an investigational platelet blocker, to standard antiplatelet therapy significantly reduces the risk of recurrent cardiovascular events in patients with known atherosclerosis, a hardening and narrowing of the arteries, according to research presented today at the American College of ...” View full resource at medicalxpress.com

• View Related
• Share

Most Recently Shared on March 26, 2012 at 1:21 pm By:

Study: PRP more effective than cortisone for severe chronic plantar fasciitis

orthosupersite.com — “Discuss in OrthoMind SAN FRANCISCO — Patients with severe chronic plantar fasciitis who received a platelet-rich plas...” View full resource at orthosupersite.com

• View Related
• Share

Most Recently Shared on February 22, 2012 at 8:06 pm By:

What Exercise + Orgasm Have In Common | Sara Gottfried MD

saragottfriedmd.com — “You know how good exercise is for you: it's a major de-ager, as effective as an anti-depressant when you're moody or depressed, helps you boost metabolism, etc. In Systems Theory, when you perturb a system, the system resists the perturbation. The rebound has a fancy name, which is harmonic oscillation.” View full resource at saragottfriedmd.com

• View Related
• Share

Most Recently Shared on January 26, 2012 at 11:46 pm By:

Dexilant Labeling Updated with Plavix Coadministration Information - MPR

empr.com — “Takeda announced that it has updated the product labeling for Dexilant (dexlansoprazole) to include information demonstrating that Dexilant had no clinically important effect on exposure to the active metabolite of clopidogrel (Plavix; Bristol-Myers Squibb and Sanofi) or clopidogrel-induced platelet inhibition.” View full resource at empr.com

• View Related
• Share

Most Recently Shared on November 17, 2011 at 7:37 pm By:

Dosing Clopidogrel Based on CYP2C19 Genotype and the Effect on Platelet Reactivity in Patients With Stable Cardiovascular Disease - — JAMA

jama.ama-assn.org — “Dosing Clopidogrel Based on CYP2C19 Genotype and the Effect on Platelet Reactivity in Patients With Stable Cardiovascular Disease - — JAMA” View full resource at jama.ama-assn.org

• View Related
• Share

Most Recently Shared on November 16, 2011 at 1:17 pm By:

World's First Bedside Genetic Test Proves Effective

medicalnewstoday.com — “Tailored anti-platelet therapy, made possible through a novel point-of-care genetic test, optimizes treatment for patients who carry a common genetic variant, researchers at the University of Otta” View full resource at medicalnewstoday.com

• View Related
• Share

Most Recently Shared on November 11, 2011 at 9:05 am By:

Results of the BRIDGE trial reported at TCT 2011

medicalxpress.com — “Data from the BRIDGE clinical trial demonstrate that intravenous use of the drug cangrelor was effective at maintaining platelet inhibition in patients on thienopyridines who required bypass surgery. Trial results were presented today at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) ...” View full resource at medicalxpress.com

• View Related
• Share

Most Recently Shared on November 9, 2011 at 10:56 pm By:

World's first bedside genetic test proves effective

medicalxpress.com — “Tailored anti-platelet therapy, made possible through a novel point-of-care genetic test, optimizes treatment for patients who carry a common genetic variant, researchers at the University of Ottawa Heart Institute (UOHI) have found.” View full resource at medicalxpress.com

• View Related
• Share

Most Recently Shared on November 9, 2011 at 8:37 pm By:

Induction of Dermal Collagenesis, Angiogenesis, and Adipogenesis in Human Skin by Injection of Platelet-Rich Fibrin Matrix -

archfaci.ama-assn.org — “Induction of Dermal Collagenesis, Angiogenesis, and Adipogenesis in Human Skin by Injection of Platelet-Rich Fibrin Matrix -” View full resource at archfaci.ama-assn.org

• View Related
• Share

Most Recently Shared on October 19, 2011 at 9:03 pm By:

MedWire News - Cardiology - Aspirin platelet aggregation effect predicts outcomes after acute coronary syndrome

medwire-news.md — “MedWire News The effect aspirin has on platelet aggregation varies greatly among patients with acute coronary syndromes and significantly predicts long-term outcomes, scientists believe. MedWire News” View full resource at medwire-news.md

• View Related
• Share

Most Recently Shared on August 25, 2011 at 11:38 am By:

Neurology Article | cerebrovascular disorders

mdlinx.com — “Differential effect of clopidogrel and aspirin on the release of BDNF from platelets” View full resource at mdlinx.com

• View Related
• Share

Most Recently Shared on August 4, 2011 at 7:07 pm By:

bit.ly View full resource at bit.ly

• View Related
• Share

Most Recently Shared on July 28, 2011 at 12:47 pm By:

Internal Medicine Article | Diabetes Mellitus, Type 2

mdlinx.com — “Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus” View full resource at mdlinx.com

• View Related
• Share

Most Recently Shared on July 21, 2011 at 7:13 pm By:

Oncology Article | Carboplatin Ovarian Neoplasms Paclitaxel

mdlinx.com — “Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/ refractory epithelial ovarian cancer” View full resource at mdlinx.com

• View Related
• Share

Most Recently Shared on July 13, 2011 at 7:49 am By: